Explore 3 Stock Ideas & Industry Insights Download Free Report

Advanced Health Intelligence Ltd

Company price
None USD 0.00(0%)
Last update at 2024-03-05T21:02:05.236594Z
Market Cap
15.94M

Momentum Score

…

Advanced Health Intelligence Ltd. operates as a mobile application and technology development company in Australia and internationally. It offers biometric health assessments, a multi-step process that employs facial scanning, heart rate measurements, body composition analysis, and cardiovascular fitness tests that evaluates an individual's health. The company also provides FaceScan, process that estimates on heart rate, respiration rate, blood pressure, and other through facial scans; BodyScan, a smart body composition and dimensioning technology that enables user to check and assess body dimensions using a smartphone; and DermaScan, a dermatological scanner. It serves mobile health and telehealth, life and health insurance, wellness, and government sectors. The company was formerly known as Advanced Human Imaging Limited and changed its name to Advanced Health Intelligence Ltd. in December 2022. Advanced Health Intelligence Ltd. was incorporated in 2014 and is based in South Perth, Australia.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

52 Week Price Range
0.64
Low
13.04
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High

Key Metrics*

Previous Close
-
Dividend Yield
-
Revenue TTM
0.65M
Revenue Per Share
0.11
Gross Profit TTM
-5.77M
Debt / Equity
0.14
ROE
-242.41%
Net Debt
-4.85M
ROCE
-218.76%
Diluted EPS TTM
-0.33

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2023-06-30 2022-06-30 2021-06-30 2020-06-30 2019-06-30
Type yearly yearly yearly yearly yearly
Date 2023-06-30 2022-06-30 2021-06-30 2020-06-30 2019-06-30
Income before tax -20.08M -20.97M -14.85M -6.06M -4.89M
Net income -20.08M -20.08M -14.06M -5.40M -4.36M
Selling general administrative 4.44M 17.14M 1.69M 1.42M 0.93M
Selling and marketing expenses 2.11M 2.11M 1.45M 1.27M 0.33M
Gross profit -11.49M -21.14M -9.27M -3.65M -3.67M
Reconciled depreciation 0.31M 0.36M 0.35M 0.25M 0.20M
Ebit -18.85M -21.40M -12.38M -6.34M -5.50M
Ebitda -18.56M -18.82M -12.33M -6.30M -5.47M
Depreciation and amortization 0.29M 2.58M 0.04M 0.04M 0.03M
Operating income -18.85M -21.40M -12.38M -6.34M -5.50M
Other operating expenses 20.34M 19.77M 15.25M 6.17M 4.91M
Interest expense 0.16M 0.16M 0.25M 0.14M 0.14M
Tax provision 0.00M -0.89M -0.78M -0.67M -0.53M
Interest income 0.25M 0.16M 0.04M 0.00M 0.00M
Net interest income -0.22M -0.01M -0.21M -0.14M -0.14M
Income tax expense -0.89M -0.89M 0.78M 0.67M 0.53M
Total revenue 0.27M 0.26M 0.61M 0.25M 0.15M
Total operating expenses 8.58M 19.77M 5.36M 2.27M 1.08M
Cost of revenue 11.76M 21.40M 9.89M 3.90M 3.82M
Total other income expense net -1.22M 0.43M -2.47M 0.28M 0.61M
Net income from continuing ops -12.83M -20.08M -14.06M -5.40M -4.36M
Net income applicable to common shares -12.83M -22.64M -14.06M -5.40M -4.36M
Breakdown 2023-06-30 2022-06-30 2021-06-30 2020-06-30 2019-06-30
Type yearly yearly yearly yearly yearly
Date 2023-06-30 2022-06-30 2021-06-30 2020-06-30 2019-06-30
Total assets 10.66M 10.66M 5.42M 2.95M 2.63M
Intangible assets 0.97M 0.97M 1.22M 1.37M 1.45M
Other current assets 0.90M 0.90M 0.91M 0.29M -
Total liab 2.11M 2.11M 3.44M 2.49M 2.08M
Total stockholder equity 8.56M 8.56M 1.98M 0.46M 0.55M
Other current liab 0.75M 0.75M 0.65M 0.75M 0.48M
Common stock 61.82M 61.82M 39.21M 24.36M 13.78M
Capital stock 76.01M 61.82M 39.21M 24.36M 13.78M
Retained earnings -62.61M -62.61M -42.53M -28.47M -23.16M
Other liab 0.55M 0.06M - - -
Good will 3.21M - - - -
Other assets 0.07M 0.04M 0.04M 0.11M 0.52M
Cash 6.01M 6.01M 2.17M 0.63M 0.57M
Total current liabilities 2.05M 2.05M 3.39M 2.03M 2.08M
Current deferred revenue - - 0.13M - -
Net debt -4.85M -4.85M 0.14M 0.77M 0.92M
Short term debt 1.16M 1.16M 2.27M 0.93M 1.50M
Short long term debt 1.43M 1.11M 2.18M 0.86M 1.50M
Short long term debt total 1.16M 1.16M 2.32M 1.39M 1.50M
Other stockholder equity 8.56M 8.56M 5.29M 4.58M 9.93M
Property plant equipment 0.51M 0.13M 0.16M 0.25M 0.06M
Total current assets 6.96M 6.96M 3.32M 1.22M 0.60M
Long term investments 0.76M 2.57M 0.04M 0.04M 0.04M
Net tangible assets -2.29M 5.02M 0.76M -0.91M -0.90M
Net receivables 0.05M 0.05M 0.24M 0.29M 0.03M
Long term debt - - - 0.32M -
Inventory - - - 0.00M 0.00M
Accounts payable 0.14M 0.14M 0.34M 0.34M 0.10M
Accumulated other comprehensive income 9.34M 9.34M 5.29M 4.58M 9.93M
Non currrent assets other 2.60M 2.60M 0.04M 0.07M 0.48M
Non current assets total 3.71M 3.71M 2.10M 1.73M 2.03M
Capital lease obligations 0.37M 0.05M 0.14M 0.21M -
Breakdown 2023-06-30 2022-06-30 2021-06-30 2020-06-30 2019-06-30
Type yearly yearly yearly yearly yearly
Date 2023-06-30 2022-06-30 2021-06-30 2020-06-30 2019-06-30
Investments 0.13M -3.13M -2.76M -2.76M -2.76M
Change to liabilities 3.03M -0.19M -0.05M 0.45M -0.04M
Total cashflows from investing activities -0.67M -3.38M -3.44M -0.08M -0.24M
Net borrowings -0.34M 0.99M 0.85M 0.91M 0.90M
Total cash from financing activities 17.08M 17.08M 9.09M 2.84M 3.90M
Change to operating activities 0.44M 0.02M -0.48M 0.11M -0.49M
Net income -20.08M -20.08M -14.06M -5.40M -4.36M
Change in cash 3.84M 3.84M 1.54M 0.05M 0.40M
Begin period cash flow 2.17M 2.17M 0.63M 0.57M 0.17M
End period cash flow 6.01M 6.01M 2.17M 0.63M 0.57M
Total cash from operating activities -9.86M -19.71M -4.10M -2.70M -3.26M
Issuance of capital stock 5.00M 18.23M 8.63M 2.05M 3.20M
Depreciation 0.36M 0.36M 0.11M 0.07M 0.03M
Other cashflows from investing activities 0.12M -0.17M 0.07M 0.08M -0.15M
Dividends paid 0.00M - 7.26M 1.22M 1.55M
Change to inventory - - 0.00M 0.00M 0.00M
Change to account receivables 0.19M 0.19M 0.05M -0.27M 0.11M
Sale purchase of stock - - -0.40M -0.12M -0.20M
Other cashflows from financing activities -1.06M -1.06M 9.09M 2.84M 4.35M
Change to netincome 1.85M 12.40M 10.09M 2.17M 1.32M
Capital expenditures 0.09M 0.09M 0.02M 0.06M 0.04M
Change in working capital 0.19M - 0.06M -0.27M 0.11M
Stock based compensation 8.43M - 7.30M 2.07M 1.21M
Other non cash items 9.85M 19.71M 9.85M 2.63M -0.24M
Free cash flow -9.95M -19.80M -4.13M -2.76M -3.30M

Peer Comparison*

Sector: Technology Industry: Software - Application

Stock Name
Change
(USD)
Price
(USD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
Enterprise Value
to EBITDA (x)
SAP
SAP SE ADR
-10.08
4.14%
233.45 28.16 22.42 6.52 4.85 5.60 16.61
CRM
Salesforce Inc
-8.76
3.94%
213.65 23.41 15.55 4.79 5.56 5.55 14.88
SAPGF
SAP SE
-7.43
3.09%
233.00 76.28 22.88 5.61 3.84 5.59 26.18
SHOP
Shopify Inc
5.16
3.59%
148.91 90.18 53.19 12.70 13.17 12.23 67.86

Profile*

Advanced Health Intelligence Ltd

Advanced Health Intelligence Ltd. operates as a mobile application and technology development company in Australia and internationally. It offers biometric health assessments, a multi-step process that employs facial scanning, heart rate measurements, body composition analysis, and cardiovascular fitness tests that evaluates an individual's health. The company also provides FaceScan, process that estimates on heart rate, respiration rate, blood pressure, and other through facial scans; BodyScan, a smart body composition and dimensioning technology that enables user to check and assess body dimensions using a smartphone; and DermaScan, a dermatological scanner. It serves mobile health and telehealth, life and health insurance, wellness, and government sectors. The company was formerly known as Advanced Human Imaging Limited and changed its name to Advanced Health Intelligence Ltd. in December 2022. Advanced Health Intelligence Ltd. was incorporated in 2014 and is based in South Perth, Australia.

71-73 The Esplanade, South Perth, WA, Australia, 6151

61 8 6244 0388

Name Title Year Born
Dr. Katherine Iscoe B.A, B.A., M.Sc., MSc, Ph.D. Co-Founder & Exec. Director NA
Mr. Vlado Bosanac Co-Founder & Head of Strategy 1967
Mr. Simon Durack B.Com., F.C.A., FCIS, J.P. CFO & Company Sec. NA
Mr. Scott Montgomery CEO & Exec. Director NA
Ms. Nadine Amesz Operations Officer NA
Mr. Terence Stupple Chief Technology Officer 1979
Dr. Amar El-Sallam Chief Science Officer 1972
Ms. Anita Swan Marketing Director NA
Mr. Ryan Snowden Chief Design Officer NA
Mr. Brian Kirkbride Strategic Advisor NA

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Support

Hi! How can we help you today?

Loading…